Introductory discussion
|
|
- Regina Fletcher
- 5 years ago
- Views:
Transcription
1 Billina R. Shaw, MD Assistant Professor University of Maryland School of Medicine Department of Psychiatry Division of Child and Adolescent Psychiatry Introductory discussion Prescribing trends in foster care youth The diagnostic assessment Overview of the medication evaluation Major psychotropic medication classes Role of the advocate in mental health care of 1
2 What is your first thought when you think of pediatric psychopharmacology? How do you feel about medicating children? What do you see as the role of medications in treatment? Sequence of treatment? Frequency of use? Etc? Medicaid populations disproportionately receive polypharmacy and antipsychotic medications Foster care youth are medicated at higher rates approximately 3 11 times higher than that of non foster care youth Children in foster care who receive at least one psychotropic medications are receiving three or more medications There remains a high degree of unmet need of children with mental health concerns 2
3 Why do you think this is the case? Too few child psychiatrists/prescribers Pediatricians wary of prescribing Too few therapists trained in evidenced-based therapies Many children and adolescents with mental health problems 3
4 Something happened that required them to be away from their family of origin Trauma Neglect They are away from their family Emotional and logistical implications 4
5 Obtaining diagnostic impression and formulation Learn about strengths and weakness of child Assess safety Build rapport with provider and/or agency Begin psychoeducation Begin to develop treatment plan May or may not include medication management Can be completed by a psychiatrist and/or LCSW C Requires an informed caretaker/guardian and the patient Typically an hour or more for the interview Will need additional time for registration, completion of paperwork, etc. May occur over more than one session 5
6 Inattention ADHD Depression Anxiety PTSD Intellectual Disability Hearing problems Language Disorder Oppositional Defiant Disorder 6
7 pedia.com Genetic predispositions Ie. ADHD In utero exposures Ie. Substances/Alcohol Developmental problems Toxins Ie. Lead poisoning Medical problems Ie. Hearing/vision problems 7
8 Temperament Thoughts Feelings Behaviors Psychological mindedness School Peers Trauma Family 8
9 Chief Complaint History of Present Illness Past Psychiatric History Medical and Psychiatric Review of Systems Family History Social History Developmental History Past Medical History Medications Allergies Assessment Plan 9
10 Chief Complaint History of Present Illness Open ended questions Closed ended questions 5 W s Review of systems ADHD ODD/Conduct Learning Disorders Depression Anxiety Trauma Past inpatient treatment Past outpatient treatment Past partial hospitalization or day program treatment Past medication trials 10
11 Mental Health Substance Abuse Suicides/attempts Learning Concerns School Repeated grades IEP School changes Learning concerns Peers Friends Bullying Family DSS involvement Trauma DJS involvement 11
12 Treatment options Medications Individual therapy Group therapy Family therapy School advocacy Children should come with an informed adult The guardian making medical decisions should be readily available Have the legal paperwork/court order Obtain and pass along medical and mental health records Attempt to have the child continue with the prior mental health/medical providers Continuity of care Attachment Ask questions 12
13 What is the role of the medication evaluation visit? 13
14 Continue to clarify diagnosis Engagement Initiate and monitor medications Monitor medication safety BP/heart rate Labs Treatment planning Therapy modalities PRP TBS Mentor Use of clinical interview, assessment/mse, objective scales, several sources (home, school, child) Obtained through learning the child/family, possible other collateral sources Not by reading a list of symptoms from the DSM May have to happen over time 14
15 Children will most likely have more than one diagnosis (or they go to the pediatrician) Recent physical exam to rule out medical causes Labs as necessary: thyroid studies, blood count, electrolytes, glucose, liver and kidney functioning, lead level Identify risks of treating and not treating Consider all settings (home, school, etc.) Consider developmental perspective Consider degree of evidence for the treatment Consider alternative treatments (pharmacotherapy and nonpharmacotherapy) 15
16 Situation dependent Mild depression v. school refusal Clinician comfort Parent and child comfort Other factors Each medication is different General Principles Start low Go slow Stop increasing when: Remission of symptoms Intolerable side effects 16
17 Monitor side effects Lower dose (or change to lower risk medication) after acute symptoms resolve Continue to monitor adherence Consider lowering dose or discontinuation annually Need to know Should be asked in a non assuming, nonjudgmental way Work to understand and address barriers Psychoeducation about illness, role of medication, transparency goes a long way Agree to disagree on medication plan sometimes and wait until the family truly desires pharmacotherapy Child won t take it anyway if they are not ready for pharmacotherapy 17
18 Assess and document the target symptoms of the current diagnoses Likely requires targeted questions Ask in the context of how the symptoms impair functionality Focus on change in symptoms and not necessarily just this point in time Have realistic expectations Some symptoms may never go away Ask parent and the child Every drug has a risk of side effects Ask about the common side effects Sleep Appetite Is the side effect worth stopping the med? Safety side effect v. comfort side effect Is the side effect related to the med? Obtain history of past med trials Effect, side effects Look for patterns of ineffective trials 18
19 Prepare, prepare & prepare Attempt at lower stress time Slow & gradual (with exceptions) If fails, try lowest dose possible Repeat when appropriate Ask about evidenced based treatments and other adjunct treatments Cognitive behavioral theapy Trauma focused models Assist in informed consent Assist in adherence 19
20 Major Classes of Medications for Children ADHD medications Antidepressants Atypical Antipsychotics Mood stabilizers 20
21 Stimulants Alpha agonists Straterra (atomoxetine) Wellbutrin 21
22 What is the role of stimulants in ADHD treatment? First line consideration 22
23 What percentage of children diagnosed with ADHD respond to stimulants? 23
24 70 80% Caveat: Most children in foster care have more than one diagnosis and decreases the effect size Stimulants Methylphenidate Dextroamphetamine 24
25 Decrease in appetite Weight and growth suppression Sleep disturbance High blood pressure Increased pulse Zoned or zombie look Dysphoric or irritable mood/affect Sudden Cardiac death? 25
26 Name some of the stimulants Ritalin (shortest acting) Ritalin (LA/SR) Concerta (longest acting) Focalin (twice as potent) Metadate (CD/ER) Methylin (syrup/er) Daytrana (patch) Quillavant (long acting liquid solution) 26
27 Adderall (XR) Dexedrine (spansules) Vyvanse (prodrug/enantiomer) Procentra (liquid) 27
28 Rapid titration and effect Relatively safe Relatively well tolerated Can be used off label for aggression in absence of ADHD Risk of diversion Initially designed to lower blood pressure, but also have an effect on ADHD symptoms Less effective than stimulants Often used for sleep due to sedating properties Risk of diversion 28
29 Clonidine Guanfacine (tenex) Longer acting Kapvay (clonidine) Intuniv (guanfacine) Low blood pressure Low pulse Dangerous in overdose Sedation (clonidine > tenex) Rebound hypertension Pearl: Medications should be continued when a child goes in care 29
30 What is the role of alpha agonists in medication treatment of ADHD? 30
31 Adjunctive or alternative when stimulant not tolerated NE Reuptake inhibitor Less effective Takes weeks to work GI side effects (start low and go slow) Some potential side effects of stimulants and SSRIs Less abuse potential 31
32 Selective Serotonin Reuptake Inhibitor Increasing serotonin between nerve cells Other antidepressants work on Dopamine or Norepinephrine Can be effective on depression and anxiety Depressed children can be irritable and NOT depressed Antidepressants thereby can treat irritability Disruptive Mood Dysregulation Disorder is a Depressive Disorder 32
33 New Disorder in DSM 5 Severe recurrent temper outburst (verbal or physical) that are out of proportion to the stressor Developmentally inappropriate 3or more times weekly Persistent irritability between tantrums >12 months 2 settings Over age 6 Symptoms before age 10 33
34 Bipolar Disorder Oppositional Defiant Disorder DMDD trumps ODD if both criteria met Intermittent Explosive Disorder It should not ONLY co exist with or be better explained by other diagnoses like Major Depression, BUT they can be co diagnosed Another medical condition/substances Constructed from Severe Mood Dysregulation construct Previous consideration Temper Dysregulation Disorder with Dysphoria Comorbidity? ODD? Depressive Disorder? Stability of Diagnosis? Treatment? 34
35 Prozac (fluoxetine) Major Depressive D/O 8 yrs old OCD 7 yrs old Zoloft (sertraline) Major Depression and OCD 6 yrs old Lexapro (ecitalopram) Major Depressive D/O 12 yrs old Celexa (citalopram) Generalized Anxity, Major Depression, OCD 7 17 Cymbalta (duloxetine) Generalized Anxity and Major Depression 7 17 Paxil (Paroxetine) Wellbutrin (buproprion) Effexor (venlafaxine) Pristiq (desvenlafaxine) Remeron (mirtazapine) Tricyclics MAOIs 35
36 Most common = none GI discomfort, nausea (D&V=rare) Sexual Behavioral activation More common in younger children Agitation, restlessness, insomnia, impulsivity Disinhibition Black box warning on increased risk of suicide for all antidepressants used in children and adolescents Recommended monitoring guideline for suicidality (weekly for 4 wks, every other week for 4 wks, monthly) Such monitoring can be done by any mental health professional 36
37 claims database 44% decline in new dx of pediatric depression Decrease in SSRI prescribing No increase in psychotherapy Suicide rates for youth increased from SSRI or cognitive behavioral monotherapy: 1/3 to ½ will not have adequate improvement Placebo response is 24 57% in pediatric trials Modest effect sizes are similar to adult depression findings 40% who recover have another episode in 12 months 37
38 Typical and Atypical Dopamine blockade Atypical antipsychotics block dopamine as well as work on the serotonin receptor Atypical antipsychotic have less motor side effects Should not be first line unless for true psychosis or bipolar disorder Psychotic symptoms and mood lability overlap with many other diagnoses 38
39 What was the first atypical antipsychotic FDA approved for children? 39
40 What was the indication? 40
41 Risperdal Irritability associated with Autism Risperdal (Risperidone) Irritability associated with Autism 5 17 Bipolar Disorder Schizophrenia Abilify (Aripiprazole) Schizophrenia Bipolar Disorder Irritability with Autism
42 Seroquel (quetiapine) Schizophrenia Bipolar Zyprexa (olanzapine) Schizophrenia Bipolar Invega (paliperidone) Schizophrenia Saphris (asenapine) Bipolar Geodon (ziprasidone) Latuda (lurasidone) Clozaril (clozapine) 42
43 Haloperidine (haldol) Thorazine (chlorpromazine) Prolixin (fluphenazine) Extrapyramidal symptoms (EPS) Stiffness/dystonic reactions Often treated or prevented with benadryl or cogentin Can be dangerous if involving the airway Parkinsonism Tremor Tardive dyskinesia Abnormal involuntary movements of the body May be permanent 43
44 Neuroleptic malignant syndrome Symptom constellation of confusion, stiffness, vital sign changes Can be fatal Akathisia Internal drive to move Metabolic syndrome Obesity Diabetes Sedation/Dizziness Decreased blood pressure Dry mouth Constipation Gynecomastia and/or lactation Cardiac arrhythmia EKG for some medications 44
45 More susceptible to weight gain in weight neutral meds More susceptible to sedation Higher risk of EPS Generally preferred over classic mood stabilizers Abrupt discontinuation can cause withdrawal dyskinesias Labs AIMS Height, weight Diagnoses Psychosocial treatments 45
46 Very helpful in true bipolar mania True bipolar disorder in children is relatively rare Depakote (valproic acid) Primary indication is seizure disorder Lithium Naturally occurring salt Tegretol (carbamazepine) Seizure medication Trileptal (oxcarbazepine) Seizure medication Weight gain Gastrointestinal problems Sedation Rash Stevens Johnson syndrome may be fatal Decreases in blood count Liver problems Dangerous to fetus in pregnancy Polycystic ovarian syndrome Pancreatitis Tremor Hair loss Confusion Increased ammonia 46
47 Narrow therapeutic index Can be fatal/may require dialysis in overdose Nausea GI effects Dizziness Fatigue Tremor Thyroid problems Arrhythmia Increased thirst/urination Acne Hair loss Blood cell changes Increased white blood cell count Most require labs Therapeutic drug levels and monitoring for adverse effects Should not be first line unless true indication of bipolar disorder 47
48 Referral and support of all aspects of treatment including pharmacotherapy Facilitate discussion of Psychoeducation about illness and treatment plan Risks, benefits Concerns about medications Support of medication adherence An 8yo AAF presents upon referral from teacher to rule out ADHD. She sometimes does her work standing up, gets in trouble for talking too much, and has problems completing assignments Multiple strategies have been employed to aid in this including preferential seating and a behavior plan The plan works for 1 month, but the symptoms recur 48
49 The family is resistant to medications. How would you present medication management treatment to this family? Billina Shaw, MD 49
50 Dr. Gloria Reeves Dr. Mark Riddle Dr. Susan dos Reis No 17. Psychotropic Medication Use by Children in Child Welfare: Findings from the National Survey of Child and Adolescent Well Being Studyhttp:// es/opre/psych_med.pdf 50
A Brief Overview of Psychiatric Pharmacotherapy. Joel V. Oberstar, M.D. Chief Executive Officer
A Brief Overview of Psychiatric Pharmacotherapy Joel V. Oberstar, M.D. Chief Executive Officer Disclosures Some medications discussed are not approved by the FDA for use in the population discussed/described.
More informationSchedule FDA & literature based indications
Psychotropic Medication List Recommended dosages are intended to serve only as a guide for children. Recommended doses are literature based. Clinicians should consult package insert of medications for
More informationJudges Reference Table for the March 2016 Psychotropic Medication Utilization Parameters for Foster Children
Judges Reference Table for the Psychotropic Medication Utilization Parameters for Foster Children Stimulants for treatment of ADHD Preschool (Ages 3-5 years) Child (Ages 6-12 years) Adolescent (Ages 13-17
More informationReview of Psychotrophic Medications. (An approved North Carolina Division of Health Services Regulation Continuing Education Course)
Review of Psychotrophic Medications (An approved North Carolina Division of Health Services Regulation Continuing Education Course) Common Psychiatric Disorders *Schizophrenia *Depression *Bipolar Disorder
More informationPsychiatric Medications. Positive and negative effects in the classroom
Psychiatric Medications Positive and negative effects in the classroom Teaching the Medicated Child Beverly Bryant, M.D. Hattiesburg Clinic 9/17/14 Introduction According to the National Survey of Children
More informationGuide to Psychiatric Medications for Children and Adolescents
Guide to Psychiatric Medications for Children and Adolescents by Glenn S. Hirsch, M.D. The following guide includes most of the medications used to treat child and adolescent mental disorders. It lists
More information4/2/13 COMMON CLASSES OF MEDICATIONS. Child & Adolescent Behavioral Medicine & Medication Therapies. Behavioral Medicine & Medication Therapies
Child & Adolescent Behavioral Medicine & Medication Therapies Brian J Cowles, PharmD Associate Professor of Pharmacy Practice Albany College of Pharmacy & Health Sciences; Vermont Campus Behavioral Medicine
More informationTreat mood, cognition, and behavioral disturbances associated with psychological disorders. Most are not used recreationally or abused
Psychiatric Drugs Psychiatric Drugs Treat mood, cognition, and behavioral disturbances associated with psychological disorders Psychotropic in nature Most are not used recreationally or abused Benzodiazepines
More informationPSYCHIATRIC DRUGS. Mr. D.Raju, M.pharm, Lecturer
PSYCHIATRIC DRUGS Mr. D.Raju, M.pharm, Lecturer PSYCHIATRIC DRUGS Treat mood, cognition, and behavioral disturbances associated with psychological disorders Psychotropic in nature Most are not used recreationally
More informationMedications and Children Disorders
Mental Health Comprehensive Services Providing Family Stability and Developing Life Coping Skills Medications and Children Disorders Psychiatric medications can be an effective part of the treatment for
More informationCreating Partnerships. Laine Young-Walker, MD
Creating Partnerships Laine Young-Walker, MD Psychiatry is the medical specialty devoted to the study, diagnosis, treatment and prevention of mental disorders. Medical school >>>four years of residency
More informationMental Illness. Doreen L. Rasp, APN, FNP, PMHNP Advanced Behavioral Counseling
Mental Illness Doreen L. Rasp, APN, FNP, PMHNP Advanced Behavioral Counseling Moodiness Changing Bodies Narcissism Self-Esteem Ignorant Naïve Insecure Self-Centered Independent Adolescence Disorders Affecting
More informationMedications for Anxiety & Behavior in Williams Syndrome. Disclosure of Potential Conflicts. None 9/22/2016. Evaluation
Medications for Anxiety & Behavior in Williams Syndrome Christopher J. McDougle, M.D. Director, Lurie Center for Autism Professor of Psychiatry and Pediatrics Massachusetts General Hospital and MassGeneral
More informationChild & Adolescent Psychiatry (a brief overview)
Child & Adolescent Psychiatry (a brief overview) Lance Feldman, MD, FAPA, MBA, BSN Vice Chair Clinical Affairs, Department of Psychiatry Affiliate Clinical Assistant Professor, University of South Carolina
More information2013 Virtual AD/HD Conference 1
Medication for & Coexisting Conditions Part 2 Dr. Kenny Handelman Child, Adolescent & Adult Psychiatrist Halton Healthcare Adjunct Professor of Psychiatry, University of Western Ontario www.drkenny.com
More informationOhio Psychotropic Medication Quality Improvement Collaborative. Minds Matter. Toolkit. for You and Your Family. This is the property of
Minds Matter Ohio Psychotropic Medication Quality Improvement Collaborative Minds Matter Toolkit for You and Your Family This is the property of About Minds Matter Minds Matter is a project to help teens,
More informationTo Give or not to Give Medication: That is the Question
To Give or not to Give Medication: That is the Question Charmi Patel Rao, MD September 14, 2018 Introduction Board Certified Child & Adolescent Psychiatrist Clinical expertise in ECMH and Developmental
More informationBehavioral Health. Behavioral Health. Prescribing Guidelines
Behavioral Health Behavioral Health Prescribing Guidelines Attention Deficit/Hyperactivity Disorder (ADHD) Start with a first line medication, either from the methylphenidate or dextroamphetamine-amphetamine
More informationAttention Deficit Hyperactivity Disorder (ADHD) in Children under Age 6
in Children under Age 6 Level 0 Conduct comprehensive assessment and provide psychoeducation about ADHD, including clearly defined treatment expectations. Consider co-morbid developmental language disorder,
More informationNew Patient Questionnaire
4 Embarcadero Center, Suite 1400, San Francisco, CA 94111 (415) 926-7774 phone; (415) 591-7760 office@sanfranciscopsych.com New Patient Questionnaire Thank you for trusting San Francisco Psychiatry with
More informationTreating Disruptive Behavior Disorders in Children and Teens. A Review of the Research for Parents and Caregivers
Treating Disruptive Behavior Disorders in Children and Teens A Review of the Research for Parents and Caregivers e Is This Information Right for Me? This information is for you if: A health care professional*
More informationBig Lots Behavioral Health. Prescribing Guidelines for Behavioral Health
Big Lots Behavioral Health Prescribing Guidelines for Behavioral Health Prescribing for Behavioral Health This document was developed by Nationwide Children s Hospital in conjunction with Partners For
More informationMedically Accepted Indications for Pediatric Use of Psychotropic Medications by
Key: White Background: Medically Accepted Indication Yellow Backgroun: Medically Accepted Indication Status Not Ascertained Orange Background: Pediatric Indication cited, but not supported Red Background:
More informationPsychiatric Medication Guide
Psychiatric Medication Guide F O R : N E O N P R I M A R Y H E A L T H C A R E P R O V I D E R S B Y : M I C H E L L E R O M E R O, D O M A Y, 2 0 1 3 Anti-depressants TCA s & MAOI s (Tricyclic Antidepressants
More informationPsychotropic Medications in Children and Adolescents: Guide for Use and Monitoring
Psychotropic Medications in Children and Adolescents: Guide for Use and This document was developed by Community Care of North Carolina with the assistance of the Medication Management Workgroup of the
More informationDepression. University of Illinois at Chicago College of Nursing
Depression University of Illinois at Chicago College of Nursing 1 Learning Objectives Upon completion of this session, participants will be better able to: 1. Recognize depression, its symptoms and behaviors
More informationCHILD & ADOLESCENT PSYCHIATRY ALERTS, VOLUME XIV, 2012 INDEX
A Adderall Counterfeit, 31 addiction, internet CBT, 55 ADHD Adjunctive Guanfacine, 11 Counterfeit Adderall, 31 Developmental Trajectory and Risk Factors, 5 Dopamine Transporter Alterations, 14 Extended-Release
More informationDisclosure Statement. A Rational Approach to Psychopharmacology. Goals 10/28/2013
A Rational Approach to Psychopharmacology Disclosure Statement Full time employed physician with MaineGeneral Medical Center in Waterville and Augusta No conflicts of interest to disclose Goals Promote
More informationChildren s Hospital Of Wisconsin
Children s Hospital Of Wisconsin Co-Management Guidelines To support collaborative care, we have developed guidelines for our community providers to utilize when referring to, and managing patients with,
More informationPsychiatric Illness. In the medical arena psychiatry is a fairly recent field A challenging field Numerous diagnosis
Psychiatric Illness In the medical arena psychiatry is a fairly recent field A challenging field Numerous diagnosis 12,000,000 children infants through 18 y/o nation wide 5,000,000 suffer severely Serious
More informationDiagnosis & Management of Major Depression: A Review of What s Old and New. Cerrone Cohen, MD
Diagnosis & Management of Major Depression: A Review of What s Old and New Cerrone Cohen, MD Why You re Treating So Much Mental Health 59% of Psychiatrists Are Over the Age of 55 AAMC 2014 Physician specialty
More informationPSYCHIATRY INTAKE FORM
Please complete all information on this form. PSYCHIATRY INTAKE FORM Name Date Date of Birth Primary Care Physician Current Therapist/Counselor What are the problem(s) for which you are seeking help? 1.
More informationTRANSCRANIAL MAGNETIC STIMULATION & BRAIN MUSIC THERAPY
TMS - DEPRESSION HISTORY Date: Patient Name: DOB: How did you hear about TMS? What do you know about TMS? Referring Physician? Name of Practice: Name of Inpatient Treatment for Depression: Name of Inpatient
More informationADHD and. Shaw Wendi Fortuchang, M.D. Board certified in Child & Adolescent, Adult, and Forensic Psychiatry
ADHD and Beyond Shaw Wendi Fortuchang, M.D. Board certified in Child & Adolescent, Adult, and Forensic Psychiatry Overview Use of medications in children How do medications work in the brain? Risperdal?
More informationCONTRAINDICATIONS TABLE
CONTRAINDICATIONS TABLE Generic Name Brand Name Contraindications Amphetamine Salts Adderall, Adderall XR Hypersensitivity to amphetamine, dextroamphetamine, or other sympathomimetic amines Advanced arteriosclerosis
More informationGuidelines for the Utilization of Psychotropic Medications for Children in Foster Care. Illinois Department of Children and Family Services
Guidelines for the Utilization of Psychotropic Medications for Children in Foster Care Illinois Department of Children and Family Services Introduction With few exceptions, children and adolescents in
More informationSteps for Initiating Electroconvulsive Therapy Treatment
Steps for Initiating Electroconvulsive Therapy Treatment PSYCHIATRISTS CAN REFER PATIENTS FOR ECT TREATMENT AT EL CAMINO HOSPITAL BY CALLING THE ECT NURSE COORDINATOR AT 650-962-5795. Once the referral
More informationBig Lots Behavioral Health. Prescribing Guidelines for Behavioral Health
Big Lots Behavioral Health Prescribing Guidelines for Behavioral Health Prescribing for Behavioral Health This document was developed by Nationwide Children s Hospital in conjunction with Partners For
More informationManaging the Behavior Problems of Children With Fragile X Syndrome by Using Medication Ave M. Lachiewicz, MD, Duke University Medical Center
Managing the Behavior Problems of Children With Fragile X Syndrome by Using Medication Ave M. Lachiewicz, MD, Duke University Medical Center Abstract: The majority of boys and many girls with fragile X
More informationOhio Psychotropic Medication Quality Improvement Collaborative. Minds Matter. Toolkit. for Youth and Caregivers. This is the property of
Minds Matter Ohio Psychotropic Medication Quality Improvement Collaborative Minds Matter Toolkit for Youth and Caregivers This is the property of About Minds Matter Minds Matter is a statewide project
More informationUsing Drugs to Improve the Behavior of People with Autism: A Skeptical Appraisal. Alan Poling, Ph.D., BCBA-D Western Michigan University
Using Drugs to Improve the Behavior of People with Autism: A Skeptical Appraisal Alan Poling, Ph.D., BCBA-D Western Michigan University In a 2010 study of 60,641 children Mandell et al. found that: 56%
More informationRichard Heidenfelder M.D. Child, Adolescent and Adult Psychiatry 447 9th Ave San Diego, CA
*We are not accepting any New Patients who are currently taking any controlled pain medications *We are *Note: not completion accepting of the any following New Patients paperwork who and Initial are Screening
More informationPL CE LIVE February 2011 Forum
February 2011 PL CE LIVE Kristin W. Weitzel, Pharm.D., CDE, FAPhA Associate Editor and Director of Editorial Projects Pharmacist s Letter/Prescriber s Letter Atypical Antipsychotics Atypical Antipsychotics
More informationRiding the Waves: Tools for the Management of Bipolar Disorder
Riding the Waves: Tools for the Management of Bipolar Disorder Jacintha S. Cauffield, Pharm.D., BCPS, CDE Associate Professor of Pharmacy Practice Palm Beach Atlantic University Lloyd L. Gregory School
More informationThings You Might Not Know About Psychotropic Medications But Wish You Did
Things You Might Not Know About Psychotropic Medications But Wish You Did John E. Dunne, MD December 3, 2016 PAL Conference Conflicts of Interest None to report I am employed by Seattle Children s and
More informationEvidence-Based Pharmacotherapy. Emily Harris, MD, MPH, FAAP Cincinnati Children s Hospital Medical Center
Evidence-Based Pharmacotherapy Emily Harris, MD, MPH, FAAP Cincinnati Children s Hospital Medical Center CME Disclosure I have no personal financial relationships in any commercial interest related to
More informationADHD Part II: Managing Comorbities
ADHD Part II: Managing Comorbities Brett Johnson, MD Staff Psychiatrist Rady Children s Behavioral Crisis Center Assistant Clinical Professor (Voluntary), UCSD January 26, 2011 Financial Disclosure I have
More informationWelcome and thank you for choosing University of Florida Physicians!
DEPARTMENT OF PSYCHIATRY Tuesday, Division of March Child and 14, Adolescent 2017 Psychiatry 8491 NW 39 th Ave. Gainesville, FL 32606 Phone: 352-265-4357 Fax: 352-627-4163 Welcome and thank you for choosing
More informationA Primer on Psychotropic Medications. Michael Flaum, MD
The Iowa Mental Health System and Employment for Individuals with Psychiatric Conditions Iowa Vocational Rehabilitation Services Conference Des Moines, IA, September 18, 2006 A Primer on Psychotropic Medications
More informationPediatric Psychopharmacology: Erika Ryst, M.D. October 12, 2016
Pediatric Psychopharmacology: Erika Ryst, M.D. October 12, 2016 Good psychopharmacology depends on Proper use of safe and effective meds Treatment of other obvious factors (e.g., medical conditions, toxic
More informationDepression & Anxiety in Adolescents
Depression & Anxiety in Adolescents Objectives 1) Review diagnosis of anxiety and depression in adolescents 2) Provide overview of evidence-based treatment options 3) Increase provider comfort level with
More informationAD/HD is a mental disorder, and it often lasts from
short version10 WHAT WE KNOW Managing Medication for Adults with AD/HD AD/HD is a mental disorder, and it often lasts from childhood into adulthood. Medication is the basic part of treatment for adults.
More informationPsychopharmacology for Treatment of ADHD and ADHD with other co-existing psychiatric condition
Psychopharmacology for Treatment of ADHD and ADHD with other co-existing psychiatric condition Presented by Cat Dang, D.O Medical Director - Insightful Minds, Inc. Objectives Evaluation process Pharmacology
More information3/19/2018. Cynthia King, MD Associate Professor of Psychiatry UNMSOM. Autism Spectrum Disorder
Cynthia King, MD Associate Professor of Psychiatry UNMSOM Autism Spectrum Disorder 1 Identify three behavioral health concerns in ASD Identify three common families of medication that may be supportive
More information3/19/2018. Cynthia King, MD Associate Professor of Psychiatry UNMSOM
Cynthia King, MD Associate Professor of Psychiatry UNMSOM 1 2 Autism Spectrum Disorder 3 Identify three behavioral health concerns in ASD Identify three common families of medication that may be supportive
More informationPsychotropic Medications Archana Jhawar, PharmD, BCPP Clinical Faculty of UIC Pharmacy Practice Clinical Psychiatric Pharmacist Jesse Brown VA
Psychotropic Medications Archana Jhawar, PharmD, BCPP Clinical Faculty of UIC Pharmacy Practice Clinical Psychiatric Pharmacist Jesse Brown VA Goals of Medications Use least number at lowest dose to get
More informationAttention Deficit Hyperactivity Disorder State of the Art. Christopher Okiishi, MD
Attention Deficit Hyperactivity Disorder State of the Art Christopher Okiishi, MD What is ADHD? Three subtypes: Inattentive (under diagnosed, esp. in girls) Hyperactive Impulsive Combined Impairments must
More informationDementia Medications Acetylcholinesterase Inhibitors (AChEIs) and Glutamate (NMDA) Receptor Antagonist
Dementia Medications Acetylcholinesterase Inhibitors (AChEIs) and Glutamate (NMDA) Receptor Antagonist Medication Dosage Indication for Use Aricept (donepezil) Exelon (rivastigmine) 5mg 23mg* ODT 5mg Solution
More informationStudy Guidelines for Quiz #1
Annex to Section J Page 1 Study Guidelines for Quiz #1 Theory and Principles of Psychopharmacology, Classifications and Neurotransmitters, Anxiolytics/Antianxiety/Minor Tranquilizers, Stimulants, Nursing
More informationPediatric Psychopharmacology
Pediatric Psychopharmacology General issues to consider. Pharmacokinetic differences Availability of Clinical Data Psychiatric Disorders can be common in childhood. Early intervention may prevent disorders
More informationAn Overview on the Use of Psychotropic Medications
An Overview on the Use of Psychotropic Medications Marilyn B. Benoit, M.D. Chief Clinical Officer SVP, Clinical & Professional Affairs Classes of Medications Antidepressants Anti-anxiety Mood stabilizers
More informationAntidepressant Medication Strategies We ve Come a Long Way or Have We? Who Writes Prescriptions for Psychotropic Medications. Biological Psychiatry
Antidepressant Medication Strategies We ve Come a Long Way or Have We? Joe Wegmann, PD, LCSW The PharmaTherapist Joe@ThePharmaTherapist.com 504.587.9798 www.pharmatherapist.com Are you receiving our free
More informationPresentation is Being Recorded
Integrated Care for Depression & Anxiety Psychotropic Medication Management for Primary Care Providers Los Angeles County Department of Mental Health September 20, 2011 Presentation is Being Recorded Please
More informationWe ll Be Discussing. Pregnancy 4/24/2013
Joe Wegmann, PD, LCSW The PharmaTherapist Joe@ThePharmaTherapist.com 504.587.9798 www.pharmatherapist.com Are you receiving our free monthly e-newsletter? We ll Be Discussing The safety and efficacy track
More informationPsychiatry in Primary Care: What is the Role of Pharmacist?
Psychiatry in Primary Care: What is the Role of Pharmacist? Benjamin Chavez, PharmD, BCPP, BCACP Clinical Associate Professor Director of Behavioral Health Pharmacy Services January 12, 2019 Disclosure
More information9/20/2011. Integrated Care for Depression & Anxiety: Psychotropic Medication Management for PCPs. Presentation is Being Recorded
Integrated Care for Depression & Anxiety Psychotropic Medication Management for Primary Care Providers Los Angeles County Department of Mental Health September 20, 2011 Presentation is Being Recorded Please
More informationCHILD & ADOLESCENT PSYCHIATRY ALERTS, VOLUME XV, 2013 INDEX
A acceptance and commitment therapy Posttraumatic Stress, 69 ADHD Adjunctive Fatty Acids, 5 Adjunctive Guanfacine Pharmacokinetics, 27 Amantadine, 21 Atomoxetine, 23 Cancer Risk, 31 CBT for Comorbid Anxiety,
More information11/11/2018. The ABCs of Medication Management for Autism Spectrum Disorder. ABC Logging (FBA) First. ABC Logging HOW TO COMPLEMENT BEHAVIORAL THERAPY
The ABCs of Medication Management for Autism Spectrum Disorder OR HOW TO COMPLEMENT BEHAVIORAL THERAPY ABC Logging (FBA) First We need to know what, when, where and why behaviors happen. Antecedent: What
More informationMood Disorders.
Mood Disorders Shamim Nejad, MD Medical Director, Psycho-Oncology Services Swedish Cancer Institute Swedish Medical Center Seattle, Washington Shamim.Nejad@swedish.org Disclosures Neither I nor my spouse/partner
More informationCOMMONLY PRESCRIBED PSYCHOTROPIC MEDICATIONS NAME Generic (Trade) DOSAGE KEY CLINICAL INFORMATION Antidepressant Medications*
COMMONLY PRESCRIBED PSYCHOTROPIC MEDICATIONS NAME Generic (Trade) DOSAGE KEY CLINICAL INFORMATION Antidepressant Medications* Bupropion (Wellbutrin) Start: IR-100 mg bid X 4d then to 100 mg tid; SR-150
More informationAggression (Severe) in Children under Age 6
Aggression (Severe) in Children under Age 6 Level 0 Comprehensive diagnostic assessments. Refer to Principles of Practice on page 6. Evaluate and treat comorbid conditions (i.e. medical, other psychiatric
More informationAdult Depression - Clinical Practice Guideline
1 Adult Depression - Clinical Practice Guideline 05/2018 Diagnosis and Screening Diagnostic criteria o Please refer to Attachment A Screening o The United States Preventative Services Task Force (USPSTF)
More informationPromoting and Monitoring Evidenced-Based Antipsychotic Prescribing Practices in Children and Adolescents: Florida Medicaid Initiatives
Promoting and Monitoring Evidenced-Based Antipsychotic Prescribing Practices in Children and Adolescents: Florida Medicaid Initiatives Mary Elizabeth Jones, Pharm BSc, RPh Senior Pharmacist AHCA Pharmacy
More informationDrugs for Emotional and Mood Disorders Chapter 16
Drugs for Emotional and Mood Disorders Chapter 16 NCLEX-RN Review Question 1 Choices Please note Question #1 at the end of Ch 16 pg 202 & Key pg 805 answer is #4 1. Psychomotor symptoms 2. Tachycardia,
More informationIMPORTANT NOTICE. Changes to dispensing of some Behavioral Health Medications for DC Healthcare Alliance members
IMPORTANT NOTICE Changes to dispensing of some Behavioral Health Medications for DC Healthcare Alliance members These changes apply only to members covered under the DC Healthcare Alliance program Alliance
More informationCriteria for Child Psychiatrist on the Use of Selected Psychotropic Medications in Children & Adolescents
Criteria for Child Psychiatrist on the Use of Selected Psychotropic Medications in Children & Adolescents DRUG NAME INDICATIONS / ACCEPTABLE USES PRIOR STIMULANT/ADHD DRUGS Daytrana (methylphenidate) ADHD
More informationOverview and Update on Current Psychopharmacological Medications, Including New Medications in Clinical Trials
SPEAKER NOTES Overview and Update on Current Psychopharmacological Medications, Including New Medications in Clinical Trials Summarized by Thomas T. Thomas New psychotropic medications are coming on the
More informationIndex. Note: Page numbers of article titles are in boldface type. A ADHD. See Attention-deficit/hyperactivity disorder (ADHD) b-adrenergic blockers
Note: Page numbers of article titles are in boldface type. A ADHD. See Attention-deficit/hyperactivity disorder (ADHD) a-adrenergic blockers for PTSD, 798 b-adrenergic blockers for PTSD, 798 Adrenergic
More informationThe Use of ADHD Medication in the Pediatric Population
The Use of ADHD Medication in the Pediatric Population Shirin Madzhidova, PharmD Pediatric Pharmacotherapy Fellow Nova Southeastern University Objectives Discuss the importance of treatment with medications
More informationThe Mental Health and Wellbeing of Children and Adolescents who are affected by Autism and Related Disorders
The Mental Health and Wellbeing of Children and Adolescents who are affected by Autism and Related Disorders Charles Cartwright, M.D Director: YAI Autism Center March 2013 Autism Spectrum Defined by the
More informationWhat Team Members Other Than Prescribers Need To Know About Antipsychotics
What Team Members Other Than Prescribers Need To Know About Antipsychotics The Care Transitions Network National Council for Behavioral Health Montefiore Medical Center Northwell Health New York State
More informationAntidepressants. Dr Malek Zihlif
Antidepressants The optimal use of antidepressant required a clear understanding of their mechanism of action, pharmacokinetics, potential drug interaction and the deferential diagnosis of psychiatric
More informationKelly E. Williams, Pharm.D. PGY2 Psychiatric Pharmacy Resident April 16,2009
Kelly E. Williams, Pharm.D. PGY2 Psychiatric Pharmacy Resident April 16,2009 List the antipsychotics most often prescribed Compare and contrast the use and adverse effects experienced in the pediatric
More informationOBJECTIVES PSYCHOTROPIC MEDICATIONS WHAT IS PSYCHOTROPIC MEDICATION?
PSYCHOTROPIC MEDICATIONS Sally Davies, Ph.D., HSPP Licensed Psychologist OBJECTIVES 1. Identify psychotropic medications and the typical usages 2. Identify effective methods for the practical application
More informationFROM MEDICATION TO MINDFULNESS: NEW INSIGHTS INTO THE WORLD OF ANXIETY
13 th Pearl Leibovitch Clinical Day November 18th, 2014 Mounir H. Samy, MD, FRCP(C) Associate Professor of Psychiatry McGill University (ret.) FROM MEDICATION TO MINDFULNESS: NEW INSIGHTS INTO THE WORLD
More informationAppendix: Psychotropic Medication Reference Tables
Appendix: Psychotropic Medication Reference Tables How to Use these Tables These reference tables are designed to provide clinic staff with specific medication related criteria for the Polypharmacy, Cardiometabolic
More informationHumberto Nagera M.D. Director, The Carter-Jenkins Center Psychoanalyst, Children, Adolescents and Adults Professor of Psychiatry at USF Professor
The Carter Jenkins Center presents 1 Humberto Nagera M.D. Director, The Carter-Jenkins Center Psychoanalyst, Children, Adolescents and Adults Professor of Psychiatry at USF Professor Emeritus of Psychiatry
More informationToo Many Meds? How to Prevent Polypharmacy in People with Intellectual/Developmental Disabilities
Too Many Meds? How to Prevent Polypharmacy in People with Intellectual/Developmental Disabilities One definition of polypharmacy is using more medications than is medically necessary. However, it can be
More information3/19/18. Medications Used In the Mental Health Care of Children. General Pediatric Psychopharmacology Overview
Medications Used In the Mental Health Care of Children American Academy of Pediatrics Critical Issues in School Health March 22 nd 2018 Jennifer Zajac, D.O. Saachi Tarr, M.D. Vanessa Katon, D.O. Institute
More informationJoel V. Oberstar, M.D. 1
Diagnosis and Treatment of Depressive Disorders in Children and Adolescents Joel V. Oberstar, M.D. CEO & Chief Medical Officer Adjunct Assistant Professor of Psychiatry University of Minnesota Medical
More informationAntipsychotics. Something Old, Something New, Something Used to Treat the Blues
Antipsychotics Something Old, Something New, Something Used to Treat the Blues Objectives To provide an overview of the key differences between first and second generation agents To an overview the newer
More informationBipolar Disorder Demystified. Cerrone Cohen, MD FABPN, FABFM Duke Departments of Family Medicine and Psychiatry
Bipolar Disorder Demystified Cerrone Cohen, MD FABPN, FABFM Duke Departments of Family Medicine and Psychiatry Underdiagnoses of Depression In Primary Care 2005 Study of 650 primary care patients on antidepressants
More information11/2/2016 INSIDE THE MIND OF A CHILD PSYCHIATRIST: PROBLEM BEHAVIORS IN CHILDREN WITH AUTISM FACULTY DISCLOSURE
FACULTY DISCLOSURE INSIDE THE MIND OF A CHILD PSYCHIATRIST: PROBLEM BEHAVIORS IN CHILDREN WITH AUTISM KristinDawson, MD Assistant Professor University of Kentucky No commercial conflicts of Interest Salary
More information5/2/2017. By Pamela Pepper PMH, CNS, BC. DSM-5 Growth and Development
By Pamela Pepper PMH, CNS, BC DSM-5 Growth and Development The idea that diagnosis is based on subjective criteria and that those criteria should fall neatly into a set of categories is not sustainable,
More informationPharmacologic Management of ADHD
Pharmacologic Management of ADHD CHADD Presentation April 13, 2015 Peter J Chung, MD, FAAP Developmental-Behavioral Pediatrician* Assistant Clinical Professor of Pediatrics University of California Irvine
More informationParents Guide to ADHD Medications. Copyright Child Mind Institute
Copyright 2017. Child Mind Institute Children with attention-deficit hyperactivity disorder (ADHD) find it unusually difficult to concentrate on tasks, to pay attention, to sit still and to control impulsive
More informationAutism: Improving Health Care Outcomes
AUTISM AWARESS CONFERENCE Lewis County Autism Coalition 23 September 2011 Autism: Improving Health Care Outcomes Glenn C. Tripp, M.D. Developmental Behavioral Pediatrics Medical Director, Developmental
More informationPost Traumatic Stress Disorder (PTSD) versus Bipolar Disorder: Confusion in the face of chaos.
Post Traumatic Stress Disorder (PTSD) versus Bipolar Disorder: Confusion in the face of chaos. Randall Ricardi D.O. Child and Adolescent Psychiatry Phoenix Children s Hospital 6-24-17 10:50am Disclosures
More information